Adrian Adams, Founder of Impel NeuroPharma

Adrian Adams is the founder of Impel NeuroPharma. Impel NeuroPharma has raised $250M in total funding. Latest round: IPO. Based in Seattle, USA.

About Adrian Adams

Adrian Adams is the Chairman and CEO of Impel NeuroPharma, a late-stage biopharmaceutical company based in Seattle. The company focuses on developing and commercializing transformative therapies for patients with central nervous system (CNS) disorders. Adams previously served as Chairman of Impel NeuroPharma's Board of Directors starting in January 2020. He has extensive experience as a CEO of multiple public companies and in board governance for various public and private companies.

Adrian Adams at a glance

More founders in Seattle, USA (44)

Browse related founder lists (6)

Full founder directory · Investor directory · Company funding database · Fundraising library